SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-030609
Filing Date
2019-05-20
Accepted
2019-05-20 18:00:41
Documents
1
Period of Report
2019-05-16

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 10244
  Complete submission text file 0001104659-19-030609.txt   11810
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Reporting) CIK: 0001635088 (see all company filings)

State of Incorp.: D0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19840261

Mailing Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617
Business Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Issuer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations